2025-10-14 - Analysis Report
Okay, I will analyze the provided data for Intuitive Surgical Inc. (ISRG) and provide a comprehensive report in English, incorporating numerical data, analysis, and a summary.

**Report: Intuitive Surgical Inc. (ISRG) Analysis**

**Company Overview:**

Intuitive Surgical Inc. (ISRG) designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **ISRG Cumulative Return:** 62.32%
*   **VOO (S&P 500) Cumulative Return:** 96.68%
*   **Absolute Deviation:** -34.36% (ISRG is underperforming VOO by this amount)
*   **Deviation Range:** Max: 98.9, Min: -37.8, Current: -37.8
*   **Relative Deviation:** 0.0 (This indicates that the current deviation is at the lower end of its historical range relative to VOO).

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta   | Cap(B) |
|------------|---------|---------|--------|--------|--------|
| 2015-2017  | 68.0%   | 77.6%   | 40.0%  | -0.1   | 43.6   |
| 2016-2018  | 64.0%   | 72.2%   | 49.0%  | -0.0   | 57.2   |
| 2017-2019  | 54.0%   | 72.2%   | 31.0%  | 0.2    | 70.6   |
| 2018-2020  | -6.0%   | 80.4%   | -29.0% | 0.3    | 97.8   |
| 2019-2021  | 29.0%   | 80.4%   | -18.0% | 0.6    | 128.8  |
| 2020-2022  | -23.0%  | 80.4%   | -22.0% | 1.2    | 95.1   |
| 2021-2023  | -17.0%  | 77.5%   | -18.0% | 1.7    | 120.9  |
| 2022-2024  | 36.0%   | 77.5%   | 15.0%  | 1.7    | 187.1  |
| 2023-2025  | 25.0%   | 72.7%   | -37.0% | 0.8    | 156.2  |

**Analysis:**

*   **Underperformance:** ISRG has underperformed the S&P 500 over the period examined. The negative deviation indicates that VOO has provided higher returns.
*   **Alpha & Beta:** The alpha values are volatile, indicating periods of both outperformance and underperformance compared to the market. The beta values generally show a positive correlation with the market, with recent years showing higher betas.
*   **CAGR & MDD:** The table presents the compound annual growth rate and maximum drawdown for rolling 3-year periods. High MDD values suggest significant volatility.

**2. Recent Stock Price Movement**

*   **Current Price:** 435.73
*   **Previous Close:** 429.59
*   **Change:** 1.43% (A positive change indicates an upward price movement)
*   **5-Day Moving Average:** 437.474
*   **20-Day Moving Average:** 441.1505
*   **60-Day Moving Average:** 464.0468

**Analysis:**

*   The price is below the 5-day, 20-day, and 60-day moving averages, suggesting a potential short-term downward trend or consolidation.
*   The positive change between the previous close and the current price indicates a recent upward movement. The increase of 1.43% is noteworthy.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 41.70 (Neutral, neither overbought nor oversold)
*   **PPO:** 0.0358 (Indicates slight positive momentum)
*   **Hybrid Signal:** Buy 100% of cash (Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Deviation Change:** -1.2 (Short-term decline)
*   **Expected Return:** 1292.6% (Long-term potential outperformance vs. S&P 500, if investing continually)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is neutral, providing no strong indication of overbought or oversold conditions.
*   The PPO, though positive, is quite low, suggesting limited momentum.
*   A recent decline in relative deviation indicates short-term underperformance.
*   The "Hybrid Signal" recommending buying with 100% cash is aggressive.
*   The exceptionally high expected return suggests strong long-term growth potential but should be taken with caution, as it is a projection.

**4. Recent News & Significant Events:**

*   **Analyst Report (Morningstar):** Indicates ongoing coverage and analysis of ISRG.
*   **BTIG Price Target Adjustment:** A price target reduction to $529 from $571, with a maintained "Buy" rating, suggests continued confidence but with a slightly tempered outlook.
*   **Motley Fool Articles:** Positive articles highlighting ISRG as a potentially strong long-term investment.
*   **Zacks Article:** "Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Market" indicates a recent period of relative weakness.
*   **Acquisition Approval:** European Commission cleared Intuitive Surgical's acquisition of AB Medica RAS Equipment Distribution Business

**Analysis:**

*   News is mixed, with some positive long-term outlooks but also indications of recent underperformance and a price target reduction.
*   The acquisition news is generally positive, suggesting expansion and strategic growth.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.94 (Buy)
*   **Number of Opinions:** 27
*   **Target Price:** Average: $576.95, High: $685.00, Low: $350.00

**Analysis:**

*   The analyst consensus is positive, with a "Buy" rating.
*   The target price range is wide, reflecting varying opinions on the stock's potential. The average target price suggests significant upside potential from the current price.
*   The missing information of Recent Rating Changes makes it difficult to assess the changes of analyst viewpoints.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue |
|------------|------|---------|
| 2025-07-23 | 1.84 | 2.44 B$ |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2025-07-23 | 1.48 | 2.01 B$ |

**Analysis:**

*   **Revenue Growth:** There appears to be a general upward trend in revenue over the past few quarters.
*   **EPS Fluctuation:** EPS has fluctuated.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $2.44B  | 66.31%        |
| 2025-03-31   | $2.25B  | 64.69%        |
| 2024-12-31   | $2.41B  | 68.04%        |
| 2024-09-30   | $2.04B  | 67.41%        |
| 2024-06-30   | $2.01B  | 68.30%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-06-30   | $17.85B   | 3.69%  |
| 2025-03-31   | $17.11B   | 4.08%  |
| 2024-12-31   | $16.43B   | 4.17%  |
| 2024-09-30   | $15.58B   | 3.63%  |
| 2024-06-30   | $14.71B   | 3.58%  |

**Analysis:**

*   **Revenue:** Revenue has been increasing over the past few quarters, indicating strong sales performance.
*   **Profit Margin:** Consistently high profit margins demonstrate the company's ability to maintain profitability as revenue grows.
*   **Equity:** Equity has been increasing, suggesting healthy capital accumulation.
*   **ROE:** ROE has been relatively stable, indicating consistent profitability relative to equity.

**7. Overall Summary**

Intuitive Surgical (ISRG) presents a mixed picture. While it has underperformed the S&P 500 recently, analyst consensus remains positive, with a "Buy" rating and a significant upside potential based on average target prices. The company's financial performance is strong, with growing revenue, high profit margins, and increasing equity. However, recent news indicates some short-term weakness, and technical indicators suggest a potential downward trend.

**Recommendations:**

*   **Long-term outlook:** Based on analyst consensus, strong financial performance, and positive long-term assessments in recent news, ISRG may be a suitable long-term investment. However, the high "Expected Return" should be viewed cautiously.
*   **Short-term caution:** Given recent underperformance, technical indicators, and price target adjustments, investors should exercise caution in the short term.
*   **Monitor news:** Keep an eye on news and analyst reports for further developments.

This analysis provides a comprehensive overview of ISRG based on the provided data. Investors should conduct their own due diligence before making any investment decisions.
